Share
Interventional Pulmonology Market Size, Share, and Analysis, By Product Type (Bronchoscopes, Electromagnetic Navigation Bronchoscopy Systems, Pleuroscopes, Respiratory Endotherapy Devices, Airway Stents, Pleural Catheters, Endobronchial Valves, and Bronchial Thermoplasty Systems), By Indication (Asthma, Chronic Obstructive Pulmonary Disease, Lung Cancer, Tracheal & Bronchial Stenosis, and Others), By End User (Hospitals, Ambulatory Surgical Canters, Diagnostic Canters, and Surgical Clinics) and Regional Forecasts, 2022-2032
Global Interventional Pulmonology Market size was USD 3.58 billion in 2021 and projected to grow from USD 4.1 billion in 2023 to USD 7.2 billion by 2032, exhibiting a CAGR of 6.5% during the forecast period.
Interventional pulmonology is a new field that emerged recently. Interventional pulmonology uses non-surgical, minimally invasive method to identify and treat thoracic cancer, lung cancer, tracheal cancer, and other respiratory system problems. It employs advanced devices to detect and treat a wide range of lung disorders. Few symptoms related to interventional pulmonary medicine are coughing, shortness of breath, and chest pain.
Global Interventional Pulmonology Market is expected to reach USD 7.2 billion, growing at a CAGR of 6.5% during forecast period owing to the increasing occurrence of lung cancer is boosting the growth of interventional pulmonology market. Several awareness campaigns about asthma, COPD, and other pulmonary diseases by the governments and healthcare providers are driving the growth of interventional pulmonology market. The electromagnetic navigation bronchoscopy may save high compensation, which might boost the growth of the interventional pulmonology market. Partnership with hospitals and retailers is a marketing strategy adopted by significant players in the interventional pulmonology market.
Global Interventional Pulmonology Market is classified based on the Product Type into Bronchoscopes, Electromagnetic Navigation Bronchoscopy Systems, Pleuroscopes, Respiratory Endotherapy Devices, Airway Stents, Pleural Catheters, Endobronchial Valves, and Bronchial Thermoplasty Systems. Respiratory endotherapy devices segment is expected to dominate the interventional pulmonology market in the forecast period. Respiratory endotherapy equipment are used to perform Bronchoscopic and endoscopic diagnostics and surgery.
Global Interventional Pulmonology Market is classified based on the Indication into Asthma, Chronic Obstructive Pulmonary Disease, Lung Cancer, Tracheal & Bronchial Stenosis, and Others. Asthma segment is expected to dominate the interventional pulmonology market in the forecast period. Children are more prone to asthma and it also affects people of any age.
Advancements in Technology is Expected to Boost the Growth of the Market
The demand for pulmonology treatments is increasing which has led to the increment in investment in R&D of new drugs and devices. Increasing geriatric population and the rise in incidence of respiratory diseases is expected to drive the growth of the market. The opportunities for key players in the international pulmonology market is increasing which is aiding to improve the detection and treatment of respiratory diseases, thereby diving the demand for international pulmonology market growth.
Increasing Prevalence of Respiratory Diseases is Expected to Boost the Growth of the Market
The increasing incidence of respiratory diseases like chronic obstructive pulmonary disease (COPD), lung cancer, and asthma, are driving the demand for interventional pulmonology procedures and is aiding in the growth of the market. The growing awareness about interventional pulmonology procedures is also expected to boost the growth of the Global Interventional Pulmonology Market.
High Interventional Cost of Pulmonology Procedures May Restrain the Growth of the Market
The cost of interventional pulmonology procedures is high which may limit the growth of the market. The limited reimbursement policies in few countries related to global interventional pulmonology market may restrain the patient access to these procedures, thereby restraining growth of the market.
Other Prominent Players (Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis)
Global Interventional Pulmonology Market is segmented based on regional analysis into five major regions: North America, Latin America, Europe, Asia Pacific and the Middle East and Africa. North America dominated the market in 2021 and is expected to dominate the market in the forecast period owing to the presence of large population suffering from chronic diseases like lung cancer, COPD, and airway related disorders. The well-established healthcare infrastructure and adoption of advanced technology related to interventional pulmonology are expected to boost up the growth of the market.
The COVID-19 outbreak had resulted in the economic downfall. Several countries had imposed lockdowns and travel bans to control the coronavirus spread. Covid-19 has affected several industries globally and there was lack of labour and raw materials. Deficit raw materials had affected the supply chain of global interventional pulmonology market. Only patients affected with serious conditions could be hospitalized. And there was no specific drug and treatment except for symptomatic and supportive treatments. Covid-19 had negative impact on the growth of Global Interventional Pulmonology Market.
|
ATTRIBUTE |
DETAILS |
|
Study Period |
2018-2032 |
|
Base Year |
2022 |
|
Forecast Period |
2022-2032 |
|
Historical Period |
2019-2021 |
|
Growth Rate |
CAGR of 6.5% from 2022-2032 |
|
Unit |
Value (USD Billion) |
|
Segmentation |
Main Segments List |
|
Product Type |
|
|
Indication |
|
|
End User |
|
|
By Region |
|
Global Interventional Pulmonology Market size was estimated at USD 3.58 billion in 2021 and is expected to reach USD 7.2 billion in 2032.
Interventional pulmonology is a new field that emerged recently. Interventional pulmonology uses non-surgical, minimally invasive method to identify and treat thoracic cancer, lung cancer, tracheal cancer, and other respiratory system problems. It employs advanced devices to detect and treat a wide range of lung disorders.
Respiratory Endotherapy Devices and Asthma segment accounted for the largest Global Interventional Pulmonology market share.
Key players: Boston Scientific Corporation, Dickinson and Company, HUGER Medical Instrument Co., Ltd., Smiths Group plc., Cook Medical, Olympus Corporation, FUJIFILM Corporation, Richard Wolf Corporation, Karl Storz, Taewoong Medical Co., Ltd, Vygon, PENTAX Medical, Clarus Medical LLC and Other Prominent Players are the key players in the Global Interventional Pulmonology Market.
Advancements in Technology and Increasing Prevalence of Respiratory Diseases are the factors driving the Global Interventional Pulmonology market.
Select License Type
Select License Type
FATPOS CLIENT Appriciation DURING THE PROJECT
Working with Fatpos Global, allowed us to take advantage of their knowledge and easy approach, allowing us to collect important data utilizing a variety of techniques. The results were clearly presented and explained, and FG responded to our questions with speed and expertise.
|
Swiss-based global building materials manufacturer |
The analyses and presentations Fatpos Global have produced for us have been of a very high caliber and have allowed us to proactively improve our customer relationship management. They have also done so while maintaining complete anonymity. Without any doubt, we suggest Fatpos Global to you.
|
|
Tech-powered construction company |
We appreciate the team’s punctuality, flexibility in terms of report modification, post report purchase support and pleasant reaction all around. Overall, my experience with this company was nothing but positive, and I couldn't be more grateful for their excellent service. Thank you for all that you do!
|
|
American global management consulting firm |
We are able to concentrate on the topics and implications that are most important to our clients thanks to the adaptability and responsiveness of the team at Fatpos Global. We would highly recommend this company to anyone in need of their services, and I will certainly be using them again in the future.
|
|
Headquartered in Zug, Switzerland, leading supplier of medical and surgical instrument |
To better study our client demographics, develop the ideal product-price architecture, and enhance our target marketing initiatives, we hired Fatpos Global. Every component of the project was completed, and we are very happy with the useful insights and actionable results.
|
|
Kosovan company, A leading organic fertilizers producer |
Thank you for your team's generous assistance, The final report was delivered to me, and I find it to be really helpful. Also, you may be sure that I will get in touch with you if I ever require fresh materials for market research. Gratitude once more.
|
|
German specialty chemicals company based in Cologne, Germany |
